Neuren Pharmaceuticals Ltd (NEU) — Cash Flow Reinvestment Rate
Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$5.00K (capex AU$5.00K ) from operating cash flow of AU$128.31 Million. Explore Neuren Pharmaceuticals Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Neuren Pharmaceuticals Ltd across 3 annual periods. Also explore Neuren Pharmaceuticals Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year capital reinvestment analysis for Neuren Pharmaceuticals Ltd. For live market cap and broader valuation context, see market cap of Neuren Pharmaceuticals Ltd.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.14x | AU$211.53 Million | AU$184.93 Million | AU$40.00K | ▲ +10733.4% |
| 2022 | 0.01x | AU$38.00K | AU$3.60 Million | AU$19.00K | ▲ +463.8% |
| 2018 | 0.00x | AU$12.00K | AU$6.41 Million | AU$12.00K | — |